1-3 of 3
Peter Hoogerbrugge, MD, PhD
Close
Sort by
Journal Articles

A Key Role for Tumor Suppressor BTG1 In the Regulation of Metabolic Stress Responses: Implications for Asparaginase Resistance In Pediatric Acute Lymphoblastic Leukemia.

Laurens van der Meer, Marloes Levers, Liesbeth van Emst, Joost C. van Galen, PhD, Ad Geurts van Kessel, PhD, Roland P. Kuiper, PhD, Peter Hoogerbrugge, MD, PhD, Frank N. van Leeuwen, PhD
Journal: Blood
Blood (2010) 116 (21): 1028.
https://doi.org/10.1182/blood.V116.21.1028.1028
Published: 2010
Journal Articles

Mitoxantrone Improves the Outcome of Children with Central Nervous System (CNS) Involvement at First Relapse of Acute Lymphoblastic Leukemia (ALL)-Results of the International ALLR3 Study

Ashish Narayan Masurekar, Catriona Anne Parker, BSc, MSc, PhD, Satarupa Choudhuri, Carly Leighton, Jeremy Hancock, Rosemary Sutton, Anthony V. Moorman, PhD, Phil Ancliff, Mary Morgan, MD, Nicholas Goulden, Nina Green, Tamas Revesz, MD, PhD, FRACP, Peter Hoogerbrugge, MD, PhD, Philip Darbyshire, Sharon Love, Vaskar Saha
Journal: Blood
Blood (2010) 116 (21): 3303.
https://doi.org/10.1182/blood.V116.21.3303.3303
Published: 2010
Journal Articles

Toxicity of ALL Treatment in Adolescents as Compared to That in Younger Children.

Tim Dijkema, MD, Jacqueline GrootLoonen, MD, PhD, Jos Bokkerink, MD, PhD, Peter Hoogerbrugge, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 4432.
https://doi.org/10.1182/blood.V104.11.4432.4432
Published: 2004